Robotic surgery is becoming increasingly common in pancreatic resection. Due to its retroperitoneal location, rich vascular supply, and limited exposure of the pancreas, pancreatic surgery remains technically challenging. Robotic systems overcome several limitations of conventional laparoscopy and offer a function-preserving option for selected benign or low-grade pancreatic tumors^[1,2].

We present the case of a 47-year-old woman with persistent epigastric pain for 1 day and a preoperative diagnosis of intraductal papillary mucinous neoplasm (IPMN). Preoperative magnetic resonance cholangiopancreatography (MRCP) suggested a visible separation between the lesion and the main pancreatic duct [Figure 1A]. Although an exact distance was not available from the imaging report, this finding was considered in the preoperative assessment and further evaluated intraoperatively under high-definition robotic visualization. Following informed consent, robotic resection of the pancreatic uncinate process was performed [Figure 1B]. The gastric wall was suspended using the third robotic arm, the gastrocolic ligament was opened with ultrasonic shears, and the descending and horizontal portions of the duodenum were mobilized. The superior mesenteric vein was dissected from the inferior pancreatic border, and the uncinate process with the tumor was lifted dorsally and cephalad. During the procedure, the inferior pancreatic vascular arcade was preserved, and the inferior pancreaticoduodenal artery was protected until complete tumor separation. Transected branch pancreatic ducts were ligated and closed with 4-0 PDS sutures [Figure 1C]. Figure 1D shows the reinforced resection surface. Our video demonstrates the management in detail.

The key technical challenges are accurate anatomy of the uncinate process, definition of a safe boundary from the main pancreatic duct, and preservation of the pancreaticoduodenal vascular arcade. It is of critical importance to protect the inferior pancreaticoduodenal artery intraoperatively. Additionally, meticulous closure of branch ducts can reduce the risk of postoperative pancreatic fistula. In this case, the postoperative recovery was uneventful, with preserved pancreatic endocrine and exocrine function.

In conclusion, robotic resection of the pancreatic uncinate process is a safe and feasible option for selected patients, enabling minimally invasive pancreatic function preservation.